Dr. Subhendu Basu is an established leader in biotech industry who previously headed Scientific Affairs at Emergent BioSolutions Inc. (NYSE: EBS). Dr. Basu was responsible for technical diligence for all acquisition and in-licensing activities that resulted in the addition of 10 marketed products and multiple pipeline assets, including vaccines, therapeutics, and drug-device combination products. Dr. Basu is originally from India where he earned his Bachelor of Science from the University of Mumbai before earning his PhD in Immunology and Pathology and MS in Microbiology and Immunology from the University of Maryland, School of Medicine. Prior to transitioning to biopharma, Dr. Basu served as Assistant Professor at the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine (UMSOM) in Baltimore, MD.